An Observational Study on the Effect of Sevoflurane on Airway Hyperreactivity in Children with RSV Infection During the Perioperative Period.
Overview
- Phase
- Not Applicable
- Intervention
- Sevoflurane (Volatile Anesthetic)
- Conditions
- Not specified
- Sponsor
- First Hospital of China Medical University
- Enrollment
- 97
- Locations
- 2
- Primary Endpoint
- Intraoperative ventilator parameters
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
To investigate the effects of sevoflurane on respiratory parameters and respiratory inflammation in healthy and RSV-infected under general anesthesia and to propose suitable perioperative airway protection measures for children with respiratory virus infection undergoing general anesthesia.
Investigators
Liu Weiwei
associate professor of anesthesiology department
First Hospital of China Medical University
Eligibility Criteria
Inclusion Criteria
- •Patients voluntarily joined this study and signed an informed consent form；
- •Age: 2-5 years old；
- •The patient should have a good general condition and no serious internal medicine comorbidities (ASA classification of the American Anesthesiology Association is Grade I); BMI ≤ 20;
- •Plan to undergo elective adenoidectomy or adenotonsillectomy with tracheal intubation.
Exclusion Criteria
- •Children with a history of allergic asthma;
- •Children with space-occupying lesions of the chest and lungs, or acute bronchiolitis or pneumonia;
- •Children with cardiovascular diseases that may cause cough, wheezing, and other symptoms;
- •Children who used leukotriene modulators, β2 receptor agonists, anticholinergics, theophyllines, or hormonal treatment drugs within two weeks;
- •Children allergic to propofol, sevoflurane, or other anesthetic agents;
- •Children with a family history of malignant hyperthermia;
- •Children with liver and kidney dysfunction;
- •The result of rapid antigen detection and nucleic acid test for RSV was inconsistent, or children combined with pathogen infections other than RSV;
- •Children with fever.
Arms & Interventions
Control group
The nasopharyngeal swab test for RSV antigen was negative for patients with no history of respiratory infection in the past six weeks before surgery.
Intervention: Sevoflurane (Volatile Anesthetic)
Control group
The nasopharyngeal swab test for RSV antigen was negative for patients with no history of respiratory infection in the past six weeks before surgery.
Intervention: propofol
RSV group
The nasopharyngeal swab of the RSV antigen test is positive.
Intervention: Sevoflurane (Volatile Anesthetic)
RSV group
The nasopharyngeal swab of the RSV antigen test is positive.
Intervention: propofol
Outcomes
Primary Outcomes
Intraoperative ventilator parameters
Time Frame: After induction of general anesthesia and intubation; at the end of anesthesia
Airway pressure(including Paw, PIP, Pplat), and pulmonary compliance.
Secondary Outcomes
- Inflammation response indications(After induction of general anesthesia and intubation; at the end of anesthesia)